Sudbury-based Verv Technologies has secured $140,000 from the National Research Council of Canada to help further development of its in-home blood-testing device, Vi.
Sudbury med-tech company Verv Technologies has received $140,000 from the National Research Council of Canada (NRCC) to help in the development of its in-home blood-testing device, Vi.
Announced on Oct. 29, the funding comes from NRCC’s Industrial Research Assistance Program, which provides advice, connections, and funding to help Canadian small and medium-sized businesses increase their innovation capacity and take ideas to market.
The funds will go toward further advancing the technological aspects of the Verv Vi prototype, a first of its kind.